Menu
MindStreet is a digital therapeutics platform that leverages computer-assisted cognitive behavioral therapy (CCBT) solutions to help providers deliver clinician-grade care at a scale for a fraction of the cost.
Computer-assisted cognitive behavioral therapy (CCBT) is a tech-enabled, scalable DTx platform. Resilim is MindStreet’s proprietary CCBT platform and includes a unique blend of technology, content, delivery, and engagement protocols that can result in 10x more resource, time, and cost savings than traditional CBT while delivering equivalent outcomes. Additionally, MindStreet’s depression product has been clinically validated over 20+ years through three NIH-funded randomized clinical trials published in leading, peer-reviewed journals that showed dramatic and sustained improvements
Register today to learn more about MindStreet and watch their pitch live at The 2024 OPEN MINDS Pitch Day!